Testing Treatment for Breast Cancer
common.study.values.description
“Evaluating Optimal Timing of Endocrine Therapy and Radiation Therapy in Early-stage Breast Cancer (REaCT-RETT)”
REaCT-RETT will demonstrate the non-inferiority of concurrent compared to sequential endocrine therapy in patients receiving post-operative radiotherapy for early stage breast cancer.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-no
common.study.methods.is-healthy-yes
Combination Product - Endocrine Therapy and Radiotherapy
Endocrine therapy and radiotherapy administered either concurrently or sequentially
participant.views.study.view.additional
participant.views.study.view.scientific-title
A Pragmatic Randomised, Multicentre Trial Evaluating Optimal Timing of Endocrine Therapy and Radiation Therapy in Early-stage Breast Cancer (REaCT-RETT)
common.study.values.clinical-trial-id
NCT03948568
participant.views.study.view.id
dPNAAa
